In conclusion, these results indicate that the T-bet expression increases, while the GATA-3 expression decreases and thus the T-bet/GATA-3 expression ratio increases in non-stimulated, MOG-stimulated, and PHA-stimulated PBMCs of the patients with MS. This evidence concerns the gene GATA3 and myeloid sarcoma.